Question

Difficulty: HardPatient Safety and Quality Improvement

A tertiary care hospital is preparing to integrate a novel, highly automated intravenous chemotherapy administration system across its oncology wards. In an effort to proactively prevent adverse drug events before the system is implemented, the medical executive committee mandates a Failure Mode and Effects Analysis (FMEA). Arrange the following procedural steps of this prospective quality improvement tool in the correct chronological sequence, from initial action to final implementation.

  1. 1Convene a multidisciplinary task force comprising oncology nurses, attending physicians, and clinical pharmacists.
  2. 2Map the chronological bedside workflow required to utilize the new chemotherapy system.
  3. 3Delineate all conceivable ways the intended system workflow could fail during clinical use.
  4. 4Determine the risk priority number by multiplying severity, occurrence, and detection probabilities.
  5. 5Institute targeted system-level safeguards to address the most hazardous identified vulnerabilities.

Answer

The correct sequence for a Failure Mode and Effects Analysis (FMEA) is to first convene a multidisciplinary team, map the intended clinical workflow, brainstorm potential failure modes, calculate the risk priority numbers, and finally institute targeted system-level safeguards.
Failure Mode and Effects Analysis (FMEA) is a structured, prospective approach to patient safety and quality improvement. The correct chronological execution is: 1) Form a multidisciplinary team to ensure broad clinical insight. 2) Map the intended process step-by-step to establish a baseline understanding of the workflow. 3) Brainstorm all potential failure modes for each step in the mapped process. 4) Calculate the Risk Priority Number (RPN) for each identified failure mode by multiplying its severity, likelihood of occurrence, and detectability. 5) Implement targeted interventions, prioritizing the vulnerabilities with the highest RPNs.

Step-by-Step Solution

1
Identify the required quality improvement methodology based on the clinical scenario.
The scenario describes a prospective Failure Mode and Effects Analysis (FMEA).
FMEA is uniquely utilized to proactively identify and mitigate risks prior to a new system's deployment, distinguishing it from retrospective tools like Root Cause Analysis (RCA).
2
Determine the initial organizational and preparatory steps.
The sequence begins by convening a multidisciplinary team, followed by mapping the chronological bedside workflow.
Broad frontline expertise is required to accurately model the standard operating procedure before it can be effectively critiqued for vulnerabilities.
3
Sequence the analytical and interventional phases of the FMEA cycle.
The sequence proceeds to delineating potential failure modes, then determining the risk priority number, and concluding with instituting targeted safeguards.
Potential hazards must first be identified through brainstorming before they can be objectively scored using the Risk Priority Number (RPN). Scoring must occur before resources are allocated for specific safeguard implementations.

Key Concept

Failure Mode and Effects Analysis (FMEA) is a prospective, systematic quality improvement tool used to identify and mitigate potential process vulnerabilities before adverse events occur, following a strict sequence of team formation, process mapping, hazard identification, quantitative prioritization, and intervention.
Estimated Time:1m 30s
Rate this question